CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 1,074	$ 866	$ 1,960	$ 2,014
General and administrative	1,235	1,048	2,221	2,109
Total operating expenses	2,309	1,914	4,181	4,123
Operating loss	(2,309)	(1,914)	(4,181)	(4,123)
Total other income (expense), net	143	68	246	123
Net loss	$ (2,166)	$ (1,846)	$ (3,935)	$ (4,000)
Net loss per common share:
Net loss per common share, Basic	$ (0.45)	$ (3.62)	$ (0.86)	$ (7.85)
Net loss per common share, Diluted	$ (0.45)	$ (3.62)	$ (0.86)	$ (7.85)
Weighted average number of common shares outstanding
Weighted average number of common shares outstanding, Basic	4,794,857	510,188	4,551,061	509,542
Weighted average number of common shares outstanding, Diluted	4,794,857	510,188	4,551,061	509,542